Brief: Cumberland Pharmaceuticals Reports Q2 Loss Per Share Of $0.06
Aug 11 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS REPORTS SECOND QUARTER 2020
FINANCIAL
RESULTS & COMPANY UPDATE
* Q2 ADJUSTED EARNINGS PER SHARE $0.08
* Q2 LOSS PER SHARE $0.06
* NET REVENUES FROM CONTINUING OPERATIONS DURING QUARTER
WERE $9.6
MILLION
Source text for Eikon: ID:nPn3LgFTra
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM